Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis

Rushmia Karim,1 Evripidis Sykakis,2 Susan Lightman,3 Samantha Fraser-Bell4 1Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia; 2Department of Ophthalmology, Whipps Cross University Hospital, 3UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK; 4University of S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karim R, Sykakis E, Lightman S, Fraser-Bell S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/0b9d9483ba7c4e0ea3f0f6ee4bdd092e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b9d9483ba7c4e0ea3f0f6ee4bdd092e
record_format dspace
spelling oai:doaj.org-article:0b9d9483ba7c4e0ea3f0f6ee4bdd092e2021-12-02T08:20:40ZInterventions for the treatment of uveitic macular edema: a systematic review and meta-analysis1177-54671177-5483https://doaj.org/article/0b9d9483ba7c4e0ea3f0f6ee4bdd092e2013-06-01T00:00:00Zhttp://www.dovepress.com/interventions-for-the-treatment-of-uveitic-macular-edema-a-systematic--a13307https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Rushmia Karim,1 Evripidis Sykakis,2 Susan Lightman,3 Samantha Fraser-Bell4 1Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia; 2Department of Ophthalmology, Whipps Cross University Hospital, 3UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK; 4University of Sydney, Clinical Ophthalmology and Eye Health, Sydney Adventist Hospital Clinical School, Sydney, NSW, Australia Background: Uveitic macular edema is the major cause of reduced vision in eyes with uveitis. Objectives: To assess the effectiveness of interventions in the treatment of uveitic macular edema. Search strategy: Cochrane Central Register of Controlled Trials, Medline, and Embase. There were no language or data restrictions in the search for trials. The databases were last searched on December 1, 2011. Reference lists of included trials were searched. Archives of Ophthalmology, Ophthalmology, Retina, the British Journal of Ophthalmology, and the New England Journal of Medicine were searched for clinical trials and reviews. Selection criteria: Participants of any age and sex with any type of uveitic macular edema were included. Early, chronic, refractory, or secondary uveitic macular edema were included. We included trials that compared any interventions of any dose and duration, including comparison with another treatment, sham treatment, or no treatment. Data collection and analysis: Best-corrected visual acuity and central macular thickness were the primary outcome measures. Secondary outcome data including adverse effects were collected. Conclusion: More results from randomized controlled trials with long follow-up periods are needed for interventions for uveitic macular edema to assist in determining the overall long-term benefit of different treatments. The only intervention with sufficiently robust randomized controlled trials for a meta-analysis was acetazolamide, which was shown to be ineffective in improving vision in eyes with uveitic macular edema, and is clinically now rarely used. Interventions showing promise in this disease include dexamethasone implants, immunomodulatory drugs and anti-vascular endothelial growth-factor agents. When macular edema has become refractory after multiple interventions, pars plana vitrectomy could be considered. The disease pathophysiology is uncertain and the course of disease unpredictable. As there are no clear guidelines from the literature, interventions should be tailored to the individual patient. Keywords: uveitic macular edema, uveitisKarim RSykakis ELightman SFraser-Bell SDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 1109-1144 (2013)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Karim R
Sykakis E
Lightman S
Fraser-Bell S
Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
description Rushmia Karim,1 Evripidis Sykakis,2 Susan Lightman,3 Samantha Fraser-Bell4 1Faculty of Medicine, University of Sydney, Camperdown, NSW, Australia; 2Department of Ophthalmology, Whipps Cross University Hospital, 3UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, UK; 4University of Sydney, Clinical Ophthalmology and Eye Health, Sydney Adventist Hospital Clinical School, Sydney, NSW, Australia Background: Uveitic macular edema is the major cause of reduced vision in eyes with uveitis. Objectives: To assess the effectiveness of interventions in the treatment of uveitic macular edema. Search strategy: Cochrane Central Register of Controlled Trials, Medline, and Embase. There were no language or data restrictions in the search for trials. The databases were last searched on December 1, 2011. Reference lists of included trials were searched. Archives of Ophthalmology, Ophthalmology, Retina, the British Journal of Ophthalmology, and the New England Journal of Medicine were searched for clinical trials and reviews. Selection criteria: Participants of any age and sex with any type of uveitic macular edema were included. Early, chronic, refractory, or secondary uveitic macular edema were included. We included trials that compared any interventions of any dose and duration, including comparison with another treatment, sham treatment, or no treatment. Data collection and analysis: Best-corrected visual acuity and central macular thickness were the primary outcome measures. Secondary outcome data including adverse effects were collected. Conclusion: More results from randomized controlled trials with long follow-up periods are needed for interventions for uveitic macular edema to assist in determining the overall long-term benefit of different treatments. The only intervention with sufficiently robust randomized controlled trials for a meta-analysis was acetazolamide, which was shown to be ineffective in improving vision in eyes with uveitic macular edema, and is clinically now rarely used. Interventions showing promise in this disease include dexamethasone implants, immunomodulatory drugs and anti-vascular endothelial growth-factor agents. When macular edema has become refractory after multiple interventions, pars plana vitrectomy could be considered. The disease pathophysiology is uncertain and the course of disease unpredictable. As there are no clear guidelines from the literature, interventions should be tailored to the individual patient. Keywords: uveitic macular edema, uveitis
format article
author Karim R
Sykakis E
Lightman S
Fraser-Bell S
author_facet Karim R
Sykakis E
Lightman S
Fraser-Bell S
author_sort Karim R
title Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
title_short Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
title_full Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
title_fullStr Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
title_full_unstemmed Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
title_sort interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/0b9d9483ba7c4e0ea3f0f6ee4bdd092e
work_keys_str_mv AT karimr interventionsforthetreatmentofuveiticmacularedemaasystematicreviewandmetaanalysis
AT sykakise interventionsforthetreatmentofuveiticmacularedemaasystematicreviewandmetaanalysis
AT lightmans interventionsforthetreatmentofuveiticmacularedemaasystematicreviewandmetaanalysis
AT fraserbells interventionsforthetreatmentofuveiticmacularedemaasystematicreviewandmetaanalysis
_version_ 1718398525195157504